Cambridge Dementia Biomedical Research Unit

Profile

The Cambridge BRC has a pioneering experimental research programme in dementia centred around the Cambridge Dementia Biomedical Research Unit (BRU) and the Dementia and Neurodegeneration Research Theme.

The programme capitalizes upon unique, world-leading research in the laboratory through to patient trials in clinics and arises from the work of a collaborative group of internationally-recognized researchers who use innovative application of physical, biological and medical sciences to the problem of dementia.

The Cambridge Dementia team is part of the overall Cambridge BRC which has relevant links in genomics, population science, imaging, cell, molecular and developmental biology, and regenerative medicine. The highly collaborative nature of this integrated bench to bedside research programme underpins its unique ability to expediate the rapid and effective translations of new preclinical discoveries into successful products that will significantly impact on the diagnosis, prevention and treatment of dementia for both the individual patient and the community.

Organisation Type 
Infrastructure 
Key People 
Peter St George-Hyslop
Director
Roger Barker
Theme lead for the Dementia and Neurodegenerative Disorders
statstat
statstat
statstat

Themes

Working with

Cambridge Biomedical Research Centre

 The NIHR Cambridge Biomedical Research Centre, a partnership between the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. Based within the most outstanding NHS and University partnerships in the country, Bio Read more